Hey Kurt Berndt...

... who is starting up a research center for youths in Saltsjöbaden.

A crash course in IP strategy

"Publish, publish, publish!" Sound familiar? So to meet the researcher's wishes, do you scribble a patent application with lipstick on a napkin and send it in? At the seminar Patent Strategies in the Biotech Company, you will have the chance to find out why this might not be the best idea.

From planning stage to handshake

"Partnering is an effective tool to get in touch with the decision makers high up in an organization's administration," says Camilla Huse Bondeson at Conlega. And according to her, rigorous planning is the way to succeed.

How to get the most out of the fair

Gabor Fischer, Distribution Sales Manager Europe, Ismatec

Why are you going to Scanlab+Biotech Forum?

Annika Garnås, LAB

Why are you going to Scanlab+Biotech Forum?

Einar Pontén, Managing Director, Merck Sequant

Why are you going to Scanlab+Biotech Forum?

Young, bright and committed to labtech

, becoming the new CEO of Swedish Labtech.

Cate Poulsen, Qiagen

Why are you going to Scanlab and Biotech Forum?

Genmab fortsätter klinisk studie

Amerikanska FDA har nu get klartecken för det danska bolaget att gå vidare med kliniska studier av ett cancerpreparat.

With their hands on the legal levers

It is wonderful news for the Scandinavian scientific community. At the end of May it stood clear that Lund will host to the European Spallation Source.

The winner of the race

She learned how to work hard at an early age and her devotion has certainly paid off. Whether it is field running or running a company, the key to success is focus according to Yvonne Mårtensson.

Flerfärgad Western för digital detektion

Med Spectraplex, ett nytt Western-kit från Alpha Innotech, kan fler proteiner detekteras i samma blott med hjälp av olika färger.

Hon är ny på Stockholm Science City

Stockholm Science Citys projekt Tools of Science har fått en ny projektansvarig.

En kvarts miljard till diabetesforskning

Ett Europeiskt konsortium ska särskilt studera komplikationer vid diabetes. Flera svenska lärosäten ingår i gruppen som får en svensk koordinator.

C-Rad mot ny marknad

En del av Harvard Medical School ska testa bolagets system för avancerad strålterapi.

Vetenskapsverktyg växer

Tools of Science omfattar inte längre bara Stockholm-Uppsalaregionen.

Genmodifierad get ger medicin

Ett nytt läkemedel mot blodpropp har godkänts för försäljning i USA. Preparatet innehåller proteinet antitrombin som produceras i getter som fått en bit mänskligt DNA insatt i sina mjölkörtelceller.

Major changes to the Q-Med board

The nomination committee wants to replace half of the existing board, including the current Chairman. An Extraordinary General Meeting will take place on February 4.

Swedish top scientists to EMBO

Two Swedish top scientists will have a really good chance to influence European life science research from now on. One is from the Karolinska Institutet, and one is from the University of Uppsala.

Athera signs production partnership

The companys novel cardiovascular product will be manufactured in Germany.

Test if you carry the fat virus

In a soon future there may be a quick and simple test that could show if you are infected with Ad-36, a human adenovirus that can make you over-weight.

Almost 150 will leave Coloplast

The Danish medtech company Coloplast negotiates headcount reductions, with a total number of almost 150 employees.

Oasmia gets a confirmation

FDA has granted Oasmia an expedited review status for Paclical Vet.